Omalizumab as a Targeted Treatment for CRSwNP
The following is a summary of “Anti-IgE therapy in chronic rhinosinusitis with nasal polyps,” published in the November 2024 issue of Allergy and Immunology by Chhiba et al. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 (T2) inflammatory condition...